Allergome: The characterization of allergens based on a 2D gel electrophoresis approach

Expert Review of Proteomics

Volumn 2, Issue 5, 2005, Pages 757-765

  Chardin, Hélène ^a   Peltre, Gabriel ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

2D gel; Allergen; Diagnosis; Electrophoresis; Proteomics; Recombinant proteins; Type I allergy; Vaccination; Western blotting

Indexed keywords

ALLERGEN; FC RECEPTOR; IMMUNOGLOBULIN E;

ALLERGOME; ALLERGY; ANALYTIC METHOD; BASOPHIL; CROSS LINKING; DESENSITIZATION; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOBLOTTING; IMMUNOGLOBULIN PRODUCTION; INDUSTRIALIZATION; MAST CELL; REVIEW; TWO DIMENSIONAL GEL ELECTROPHORESIS; VACCINATION;

ALLERGENS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; ISOELECTRIC FOCUSING;

EID: 27144538575     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.2.5.757     Document Type: Review

References (32)

1. Gell PG, Coombs RR. Clinical Aspects of Immunology. Blackwell, Oxford, UK (1963).
2. Ticha M, Pacakova V, Stulik K. Proteomics of allergens. J. Chromatogr. 771, 343-353 (2002).
3. Hamilton RG, Adkinson NF. In vitro assays for the diagnosis of IgE-mediated disorders. J. Allergy Clin. Immunol. 114, 213-225 (2004). Reviews and discusses the interests and limits of actual methods (immunoassays) and future prospects (microarrays) for in vitro diagnosis of immunoglobulin E-mediated disorders.
4. Altland K, Hackler R. Concept and application of double one-dimensional slab gel electrophoresis. Fourth meeting of the International Electrophoresis Society 362-377 (1984).
5. Chardin H, Mayer C, Sénéchal H, Tepfer M, Desvaux FX, Peltre G. Characterization of high-molecular-mass allergens in oilseed rape pollen. Int. Arch. Allergy Immunol. 125, 128-134 (2001).
6. Chardin H, Mayer C, Sénéchal H et al. Polygalacturonase (pectinase), a new oilseed rape allergen. Allergy 58, 407-411 (2003).
7. Beyer K, Bardina L, Grishina G, Sampson HA. Identification of sesame seed allergens by 2-dimensional proteomics and Edman sequencing: seed storage proteins as common food allergens. J. Allergy Clin. Immunol. 110, 154-159 (2002).
8. Chardin H, Mayer C, Sénéchal H et al. Lipid transfer Protein 1 is a possible allergen in Arabidopsis thaliana. Int. Arch. Allergy Immunol. 131, 85-90 (2003).
9. Chardin H, Raulf-Heimsoth M, Chen Z et al. Interest of 2-D electrophoretic analysis for the characterization of the individual sensitization to latex allergens. Int. Arch. Allergy Immunol. 128, 195-203 (2002).
10. Yagami T, Haishima Y, Tsuchiya T, Tomitaka-Yagami A, Kano H, Matsunaga K. Proteomic analysis of putative latex allergens. Int. Arch. Allergy Immunol. 135, 3-11 (2004).
11. Corti V, Cattaneo A, Bachi A et al. Identification of grass pollen allergens by two-dimensional gel electrophoresis and serological screening. Proteomics 5, 729-736 (2005).
12. Yu CJ, Lin YF, Chiang BL, Chow LP. Proteomics and immunological analysis of a novel shrimp allergen, Pen m 2. J. Immunol. 170, 445-453 (2003).
13. Natale M, Bison C, Monti G et al. Cow's milk allergens identification by two-dimensional immunoblotting and mass spectrometry. Mol. Nutr. Food Res. 48, 363-369 (2004).
14. King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TA, Thomas W. Allergen nomenclature. Allergy 50, 765-774 (1995).
15. Aalberse RC, Akkerdaas JH, van Ree R. Cross-reactivity of IgE antibodies to allergens. Allergy 56, 478-490 (2001).
16. Lehrer SB, Reish R, Fernandes J, Gaudry P, Dai G, Reese G. Enhancement of murine IgE antibody detection by IgG removal. J. Immunol. Methods 284, 1-6 (2004).
17. Maleki SJ. Food processing: effects on allergenicity. Curr. Opin. Allergy Clin. Immunol. 4, 241-245 (2004). Describes the effects of processing and Maillard reaction on the increase or decrease of the allergenicity of food allergens.
18. Breiteneder H, Mills ENC. Molecular properties of food allergens. J. Allergy Clin. Immunol. 115, 14-23 (2005). Reviews the molecular characteristics of an allergen protein in food allergy. Numerous examples are provided to illustrate the purpose.
19. Motta AC, Dormans JA, Peltre G, Lacroix G, Bois FY, Steerenberg PA. Intratracheal instillation of cytoplasmic granules from Phleum pratense pollen induces IgE- and cell-mediated responses in the Brown Norway rat. Int. Arch. Allergy Immunol. 135, 24-29 (2004).
20. Motta A, Peltre G, Dormans JA et al. Phleum pratense pollen starch granules induce humoral and cell-mediated immune responses in a rat model of allergy. Clin. Exp. Allergy 34, 310-314 (2004).
21. Fernvik E, Peltre G, Sénéchal H, Vargaftig B. Effects of birch pollen and traffic particulate matter on Th 2-cytokines, immunoglobulin E levels and bronchial hyperresponsiveness in mice. Clin. Exp. Allergy 32, 602-611 (2002).
22. Fernvik E, Scharnweber T, Knopp D, Niessner R, Vargaftig BB, Peltre G. Effects effractions of air polluted urban dust on Th 2 cytokines, IgE levels and bronchial hyperresponsiveness in mice. J. Tax. Envir. Health Part A 65, 101-121 (2002).
23. Rhyner C, Weichel M, Flückiger S, Hemman S, Kleber-Janke T, Crameri R. Cloning allergens via phage display. Methods 32, 211-218 (2004).
24. Hiller R, Laffer S, Harwanegg CA et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J. 16, 414-416 (2002).
25. Niederberger V, Horak F, Vrtala S et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc. Natl Acad. Sci. USA 101, 14677-14682 (2004).
26. Valenta R, Kraft D. From allergen structure to new forms of allergen-specific immunotherapy. Curr. Opin. Immunol 14, 718-727 (2002).
27. Bhalla PL, Singh MB. Engineered allergens for immunotherapy. Curr. Opin. Allergy Clin. Immunol. 4, 569-573 (2004).
28. Niederberger V, Valenta R. Recombinants allergens for immunotherapy. Where do we stand? Curr. Opin. Allergy Clin. Immunol. 4, 549-554 (2004). Reviews the new developments and improvements in allergen-specific immunotherapy using recombinant molecules.
29. Saarne T, Kaiser L, Gronlund H, Rasool O, Gafvelin G, van Hage-Hamsten M. Rational design of hypoallergens applied to the major cat allergen Fel d 1. Clin. Exp. Allergy 35, 657-663 (2005).
30. Linhart B, Hartl A, Jan-Schmid B et al. A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination. J. Allergy Clin. Immunol. 115, 1010-1016 (2005).
31. Batard T, Didierlaurent A, Chabre H et al. Characterization of wild type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy. Int. Arch. Allergy Immunol. 136, 239-249 (2005).
32. Kussebi F, Karamloo F, Rhyner C et al. A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy. J. Allergy Clin. Immunol. 115, 323-329 (2005).